PY
PYC.LSE Physiomics Plc
- Market cap
- GBX 1.93M
- P/E
- -
- P/B
- 3.68x
- ROE
- -133.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is PYC.LSE undervalued?
Graham numberThe Graham number of Physiomics Plc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Physiomics Plc fundamental analysis
No fundamental analysis for Physiomics Plc yet.
Physiomics Plc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Physiomics Plc
Physiomics Plc engages in the provision of consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the f…
Full company profilePhysiomics Plc financial statements
Physiomics Plc annual financial statements (GBP; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 270K | 513K | 783K | 799K | 702K | 830K | 597K | 543K | 784K | 941K |
| Gross Profit | -489K | -257K | -179K | -177K | -366K | -429K | -582K | -677K | -435K | -797K |
| Operating Income | -489K | -260K | -201K | -177K | -337K | -359K | -574K | -671K | -458K | -797K |
| EBITDA | -525K | -257K | -193K | -125K | -325K | -348K | -562K | -660K | -448K | -788K |
| Net Income | -401K | -183K | -104K | -64.4K | -216K | -253K | -477K | -609K | -415K | -697K |
| EPS | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | ||||||||||
| Total Assets | 415K | 818K | 694K | 1.45M | 1.32M | 1.12M | 674K | 423K | 892K | 789K |
| Total Liabilities | 86.9K | 128K | 86.4K | 132K | 158K | 141K | 143K | 140K | 200K | 265K |
| Shareholders' Equity | 328K | 690K | 608K | 1.31M | 1.17M | 975K | 532K | 283K | 692K | 524K |
| Cash & Short-term Investments | 210K | 572K | 405K | 1.05M | 1.04M | 688K | 417K | 191K | 461K | 419K |
| Total Debt | - | - | - | - | - | - | 7.35K | 3.83K | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | -437K | -170K | -144K | -116K | -32.5K | -349K | -265K | -548K | -546K | -562K |
| Capital Expenditure | 6.80K | 2.33K | 21.8K | 5.09K | 16.2K | 9.37K | 6.64K | 17.3K | 3.94K | 4.43K |
| Free Cash Flow | -444K | -172K | -166K | -121K | -48.6K | -359K | -271K | -565K | -550K | -566K |
| Ratios | ||||||||||
| ROE | -122.0% | -26.6% | -17.1% | -4.9% | -18.5% | -26.0% | -89.8% | -215.7% | -60.0% | -133.0% |
| ROA | -96.5% | -22.4% | -15.0% | -4.5% | -16.3% | -22.7% | -70.8% | -144.2% | -46.6% | -88.4% |
| Net Profit Margin | -148.1% | -35.7% | -13.3% | -8.1% | -30.7% | -30.5% | -79.9% | -112.2% | -53.0% | -74.1% |
| Debt to Equity | - | - | - | - | - | - | 0.01x | 0.01x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Physiomics Plc dividends
Physiomics Plc has not paid dividends in the last 10 fiscal years.
Last stock split: 1:100 on Dec 19, 2016.
Who owns Physiomics Plc
- Insiders 25.73%
- Institutions 2.30%
- Public & others 71.96%
- Shares outstanding 453M
- Free float 304M
Physiomics Plc company profile
- Company name
- Physiomics Plc
- Ticker
- PYC.LSE
- ISIN
- GB00BDR6W943
- Exchange
- London Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 11
- Fiscal year end
- June
- Address
- Milton Park Innovation Centre, Oxford, United Kingdom, OX14 4RY
- Phone
- 44 123 5841575
- Website
- physiomics.co.uk
About Physiomics Plc
Physiomics Plc engages in the provision of consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.
Physiomics Plc management
5- Mr. Ian Russell BagnallCompany Secretary, Finance Director & Non-Executive Director · born 1965
- Mr. Michael David WhitlowExecutive Director · born 1979
- Mr. Jesse ThissenCOO & Head of Biometrics
- Ms. Hayley CloseHead of Business Development
- Dr. Venkata PutchaHead of Biostatistics